We are live on !
Find out more
XTX Topco Portfolio holdings
AUM
$7.72B
Turnover
39.96%
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$7.72B
AUM Growth
+$1.97B
(+34%)
Cap. Flow
+$1.58B
Cap. Flow % of AUM
Cap. Flow %
20.47%
Top 10 Holdings %
Top 10 Hldgs %
3.84%
Holding
4,912
New
1,139
Increased
1,694
Reduced
1,253
Closed
824
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$41.2M |
| 2 |
Netflix
NFLX
|
+$35.5M |
| 3 |
Intercontinental Exchange
ICE
|
+$29.7M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$29.4M |
| 5 |
PepsiCo
PEP
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$35.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.9M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$24.6M |
| 4 |
NVIDIA
NVDA
|
+$23.6M |
| 5 |
Arm
ARM
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 15.06% |
| 3 | Industrials | 13.66% |
| 4 | Healthcare | 12% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Kingsway Corp
KWY
$246M
| $116K | ﹤0.01% |
+11,176
| New | +$121K |
2026 Q2
0 quarters
|
|
3477
Octave Specialty Group
OSG
$227M
| $116K | ﹤0.01% |
18,657
-98,254
| -84% | -$512K |
2025 Q4
2 quarters
|
|
3478
Inovio Pharmaceuticals
INO
$125M
| $116K | ﹤0.01% |
105,833
-106,844
| -50% | -$127K |
2024 Q4
6 quarters
|
|
3479
Ironwood Pharmaceuticals
IRWD
$729M
| $116K | ﹤0.01% |
+27,646
| New | +$107K |
2026 Q2
0 quarters
|
|
3480
EHang Holdings
EH
$294M
| $116K | ﹤0.01% |
+17,727
| New | +$165K |
2026 Q2
0 quarters
|
|
3481
Expensify
EXFY
$191M
| $116K | ﹤0.01% |
+64,764
| New | +$72.7K |
2026 Q2
0 quarters
|
|
3482
T-REX 2X Inverse CRWV Daily Target ETF
CORD
$59.7M
| $116K | ﹤0.01% |
+21,090
| New | +$133K |
2026 Q2
0 quarters
|
|
3483
Defiance Daily Target 2x Short QBTS ETF
QBTZ
$58.2M
| $115K | ﹤0.01% |
+6,031
| New | +$458K |
2026 Q2
0 quarters
|
|
3484
Cineverse
CNVS
$40.5M
| $115K | ﹤0.01% |
38,631
+7,538
| +24% | +$19.4K |
2025 Q1
5 quarters
|
|
3485
Aardvark Therapeutics
AARD
$25.6M
| $115K | ﹤0.01% |
19,888
-27
| -0.1% | -$126 |
2025 Q4
2 quarters
|
|
3486
Myomo
MYO
$47.9M
| $114K | ﹤0.01% |
110,028
+6,933
| +7% | +$6.76K |
2025 Q4
2 quarters
|
|
3487
Outdoor Holding Co
POWW
$267M
| $114K | ﹤0.01% |
50,013
-5,178
| -9% | -$10.7K |
2025 Q3
3 quarters
|
|
3488
iShares MSCI Indonesia ETF
EIDO
$382M
| $114K | ﹤0.01% |
+10,082
| New | +$141K |
2026 Q2
0 quarters
|
|
3489
Cingulate
CING
$62.8M
| $114K | ﹤0.01% |
20,818
-32,685
| -61% | -$165K |
2025 Q4
2 quarters
|
|
3490
Nerdy
NRDY
$51.8M
| $114K | ﹤0.01% |
8,273
-6,028
| -42% | -$78.7K |
2025 Q3
3 quarters
|
|
3491
Allspring Global Dividend Opportunity Fund
EOD
$261M
| $113K | ﹤0.01% |
+17,254
| New | +$110K |
2026 Q2
0 quarters
|
|
3492
Definitive Healthcare
DH
$124M
| $112K | ﹤0.01% |
135,370
+111,863
| +476% | +$102K |
2024 Q3
7 quarters
|
|
3493
Gain Therapeutics
GANX
$44.1M
| $112K | ﹤0.01% |
+55,294
| New | +$102K |
2026 Q2
0 quarters
|
|
3494
Voyager Therapeutics
VYGR
$117M
| $112K | ﹤0.01% |
+32,058
| New | +$122K |
2026 Q2
0 quarters
|
|
3495
CVRx
CVRX
$23.4M
| $112K | ﹤0.01% |
21,825
-404
| -2% | -$2.61K |
2025 Q4
2 quarters
|
|
3496
Eaton Vance Floating-Rate Income Trust
EFT
$283M
| $112K | ﹤0.01% |
+10,362
| New | +$112K |
2026 Q2
0 quarters
|
|
3497
Spero Therapeutics
SPRO
$60M
| $112K | ﹤0.01% |
+50,536
| New | +$132K |
2026 Q2
0 quarters
|
|
3498
PIMCO Income Strategy Fund
PFL
$348M
| $112K | ﹤0.01% |
+14,170
| New | +$111K |
2026 Q2
0 quarters
|
|
3499
BNY Mellon High Yield Strategies Fund
DHF
$161M
| $111K | ﹤0.01% |
45,924
+29,817
| +185% | +$72.2K |
2026 Q1
1 quarter
|
|
3500
Scully Royalty
SRL
$61.7M
| $111K | ﹤0.01% |
18,140
+2,143
| +13% | +$15K |
2026 Q1
1 quarter
|
|
Similar funds
XTX Topco's Q2 2026 Portfolio in Review
As of Q2 2026, XTX Topco held 4,912 positions worth $7.72B, up 34% from $5.75B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.
XTX Topco deployed $1.58B of net new capital in Q2 2026, opening 1,139 new positions and adding to 1,694 existing holdings. Its largest new stake was Netflix: 403,127 shares worth $28.8M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $29.9M trimmed.
- XTX Topco's largest Q2 2026 buy was Netflix: 403,127 shares worth $28.8M.
- XTX Topco added most to Chevron in Q2 2026, an estimated $41.2M increase.
- XTX Topco's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.9M.
- XTX Topco fully exited iShares MSCI South Korea ETF in Q2 2026, selling an estimated $35.4M.
- XTX Topco's ten largest holdings make up 3.8% of its $7.72B portfolio in Q2 2026.
- XTX Topco opened 1,139 new positions and closed 824 in Q2 2026.
- XTX Topco's portfolio value rose 34% quarter-over-quarter to $7.72B.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.